Thus, we performed this meta-analysis to evaluate the effects of XPD Asp312Asn (G>A) and Lys751Gln (A>C) polymorphisms on the efficacy of platinum-based chemotherapy in advanced NSCLC by assessing therapeutic response (TR), progression-free survival, and overall survival. Here, ERCC2 is linked to non-small cell lung carcinoma.